The number of anti-epilepsy treatments accessible has doubled in recent decades, owing to the fact that the advantages of anti-epilepsy medications outweigh the risks of side effects. Furthermore, the FDA has approved 28 medications for the treatment of epilepsy, and manufacturers have produced various generic versions of anti-epileptic pharmaceuticals. Only anticonvulsant drugs for children have been approved by the FDA in the United States. Furthermore, the currently available newer anti-seizure medications have simple pharmacokinetics and have less side effects on liver metabolism, propelling the anti-epileptic drug market for kids to new heights. The anti-epileptic pharmaceuticals market is expected to rise due to rising advancements in the efficacy of medications for treating epilepsy. Newer medications, for example, have shown superior efficacy than older drugs, owing to improved pharmacokinetic profiles and fewer drug interactions. For example, the third-generation drugs developed by UCB’s Keppra (levetiracetam) and GlaxoSmithKline’s (GSK’s) Lamictal (lamotrigine) transitioned rapidly to the ‘Blockbuster’ status and have replaced the older gold standards in most of the markets as first-line treatments. According to a 2013 Epileptic Foundation report, newer third-generation AEDs have given total control of seizures to more than half of epilepsy patients and reduced the number of seizures in another 20-30% of patients, demonstrating the newer AEDs’ success rate.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1701
Key Takeaways of the Global Anti-epileptic Drugs Market:
Due to the advent of novel effective anti-epileptic medications, the worldwide anti-epileptic drug market is predicted to grow at a CAGR of 6.6 percent over the forecast period (2019-2027).
By 2027, the third generation segment is expected to account for the majority of revenue, owing to increasing demand for third generation anti-epileptic drugs, which is rapidly outpacing demand for first and second generation anti-epileptic drugs, primarily for the treatment of children and adolescents. • Novartis AG, GlaxoSmithKline Plc, Johnson & Johnson Service, Inc., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co., Ltd., Mylan N.V., Bausch Health Companies Inc., and UCB S.A. are among the major participants in the global anti-epileptic medicine market.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/1701
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Generation
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Market Opportunities
- Market Trend
- Impact Analysis
- Impact of COVID-19 on the Global Anti-epileptic Drugs Market
- COVID-19 Epidemiology
- Overall Impact on Healthcare Sector
- Impact of COVID-19 on Epilepsy Patients
- Government Recommendations
- Global Anti-epileptic Drugs Market, By Generation, 2017 – 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- First Generation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Second Generation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Third Generation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Anti-epileptic Drugs Market, By Route of Administration, 2017 – 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Anti-epileptic Drugs Market, By Distribution Channel, 2017 – 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Anti-epileptic Drugs Market, By Region, 2017 – 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Regional Trends
- North America
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Generation, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Generation, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Generation, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Generation, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Generation, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Overview
- Market Size and Forecast, and Y-o-Y Growth, By Generation, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837